Aim High rates of anxiety have been observed in youth at clinical high risk ( CHR ) of developing
psychosis. In CHR , anxiety often co‐occurs with depression, and there is inconsistent …

Aim Anxiety is a common presenting concern for individuals at clinical high risk ( CHR ) for
psychosis. Treatment for CHR is still in the early stages and has focused on transition to …

Over the past 15 years, deep brain stimulation (DBS) has been actively investigated as a
groundbreaking therapy for patients with treatment-resistant depression (TRD); nevertheless, …

Theta burst stimulation (TBS) is approved and widely used in the treatment of treatment
resistant-major depression. More recently, accelerated protocols delivering multiple treatments …

Accessible Summary What is known on the subject? Major depressive disorder is the most
prevalent of all mental illnesses. 10%–20% of patients with depression and 1% of the …

Background Anxiety disorders are the most common psychiatric problems among Canadian
youth and typically have an onset in childhood or adolescence. They are characterized by …

Background: Deep brain stimulation (DBS) is a promising investigational approach for
treatment-resistant depression. However, reports suggesting changes in personality with DBS for …

Background: Clinical practice guidelines recommend the use of fluoxetine, a selective serotonin
reuptake inhibitor (SSRI), as a first-line pharmacotherapy for major depressive disorder (…

Objectives Amphetamine-based medications are recommended as a first-line pharmacotherapy
for the treatment of attention-deficit/hyperactivity disorder in children and adolescents. …

Background Theta burst stimulation (TBS) is a newer form of repetitive transcranial magnetic
stimulation (rTMS) with proven efficacy and safety in the treatment of major depressive …